Literature DB >> 3487613

Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1.

P M Cameron, G A Limjuco, J Chin, L Silberstein, J A Schmidt.   

Abstract

Two anionic species of human IL-1 have been purified to homogeneity. These molecules were characterized as having pI of 5.4 and 5.2 and molecular weights identical to IL-1/6.8 (17,500). The specific activities of IL-1/5.4 and IL-1/5.2, as measured in the mouse thymocyte co-mitogenic assay, were identical to that of IL-1/6.8, namely 1.2 X 10(7) U/mg, with half-maximal stimulation observed at 2 X 10(-11) M. IL-1/5.4 and IL-1/5.2 were found to be antigenically distinct from IL-1/6.8 in an ELISA. IL-1/5.4 was structurally distinct from IL-1/6.8 based on reverse-phase HPLC or CNBr peptides. Intact IL-1/5.2 and three intact CNBr peptides of IL-1/5.4 were sequenced, with the identification of 74 amino acid residues. These sequences were found to correspond exactly with the amino acid sequence deduced from the IL-1-alpha cDNA reported by March et al.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487613      PMCID: PMC2188208          DOI: 10.1084/jem.164.1.237

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

Review 1.  Interleukin 1: an immunological perspective.

Authors:  S K Durum; J A Schmidt; J J Oppenheim
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

Review 2.  Deamidation of glutaminyl and asparaginyl residues in peptides and proteins.

Authors:  A B Robinson; C J Rudd
Journal:  Curr Top Cell Regul       Date:  1974

3.  Protein contaminants of sodium dodecyl sulfate-polyacrylamide gels.

Authors:  D Ochs
Journal:  Anal Biochem       Date:  1983-12       Impact factor: 3.365

4.  Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity.

Authors:  J H Morrissey
Journal:  Anal Biochem       Date:  1981-11-01       Impact factor: 3.365

5.  Interleukin 1, a potential regulator of fibroblast proliferation.

Authors:  J A Schmidt; S B Mizel; D Cohen; I Green
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

6.  Purification to apparent homogeneity of murine interleukin 1.

Authors:  S B Mizel; D Mizel
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

7.  Physicochemical characterization of lymphocyte-activating factor (LAF).

Authors:  S B Mizel
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

8.  Purification to homogeneity of pig leucocyte catabolin, a protein that causes cartilage resorption in vitro.

Authors:  J Saklatvala; V A Curry; S J Sarsfield
Journal:  Biochem J       Date:  1983-11-01       Impact factor: 3.857

9.  Purification of human interleukin 1 by high-performance liquid chromatography.

Authors:  A Köck; T A Luger
Journal:  J Chromatogr       Date:  1984-07-27

10.  Purification and partial biochemical characterization of normal human interleukin 1.

Authors:  J A Schmidt
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

View more
  12 in total

1.  Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha.

Authors:  P Busson; K Braham; G Ganem; F Thomas; D Grausz; M Lipinski; H Wakasugi; T Tursz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

Review 2.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

3.  Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells.

Authors:  J Chin; E Rupp; P M Cameron; K L MacNaul; P A Lotke; M J Tocci; J A Schmidt; E K Bayne
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

4.  Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha.

Authors:  Y Kobayashi; K Yamamoto; T Saido; H Kawasaki; J J Oppenheim; K Matsushima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 5.  The molecular forms of interleukin-1.

Authors:  T P Hopp; S K Dower; C J March
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

6.  Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes.

Authors:  S Bhakdi; M Muhly; S Korom; F Hugo
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

Review 7.  Early circulating erythroid progenitors (BFU-E) in sickle cell anemia.

Authors:  H Croizat
Journal:  Experientia       Date:  1993-02-15

8.  Molecular cloning and characterization of ovine IL-1 alpha and IL-1 beta.

Authors:  A E Andrews; G J Barcham; M R Brandon; A D Nash
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

9.  Specific bioactivities of monocyte-derived interleukin 1 alpha and interleukin 1 beta are similar to each other on cultured murine thymocytes and on cultured human connective tissue cells.

Authors:  E A Rupp; P M Cameron; C S Ranawat; J A Schmidt; E K Bayne
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

10.  Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta.

Authors:  B Mosley; S K Dower; S Gillis; D Cosman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.